Projects funded by the NCN

DNA repair pathways contributing to resistance to photodynamic therapy and as possible theraupeutic targets

Call: OPUS 8 , Panel: NZ5

Principal investigator: dr hab. Elżbieta Speina

Instytut Biochemii i Biofizyki PAN

Role of the selected anti-tumor agents transported by electropermeabilization to the drug-sensitive and drug-resistant c...

Call: PRELUDIUM 8 , Panel: NZ7

Principal investigator: dr Joanna Weżgowiec

Politechnika Wrocławska, Wydział Podstawowych Problemów Techniki

Immunological biomarkers of drug resistant epilepsy and response to immunomodulatory therapy with ACTH in children

Call: PRELUDIUM 6 , Panel: NZ4

Principal investigator: Magdalena Kaczorowska-Frontczak

Instytut "Pomnik - Centrum Zdrowia Dziecka"

"One step to game changer": combined antimicrobial therapy based on AI and nanotechnology to combat challenging diabetes...

Call: SONATA 19 , Panel: NZ7

Principal investigator: dr Barbara Pucelik

Sieć Badawcza Łukasiewicz – Krakowski Instytut Technologiczny

Extensive analysis of the immunological profile of pediatric patients with acute lymphoblastic leukemia in order to iden...

Call: PRELUDIUM 22 , Panel: NZ5

Principal investigator: Anna Krętowska-Grunwald

Uniwersytet Medyczny w Białymstoku

Unlocking nature's potential - exploring the ability of newly isolated from the environment bacteriophage and its enzyme...

Call: PRELUDIUM 22 , Panel: NZ9

Principal investigator: Aleksandra Łukasiak

Uniwersytet Gdański, Wydział Biologii

Unveiling the molecular signature underlying resistance to CD19 CAR-T therapy in malignant cells.

Call: PRELUDIUM 22 , Panel: NZ7

Principal investigator: Marta Krawczyk

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

The use of genetic analysis of liquid biopsy for predicting and monitoring ofresponse to therapies and tumor evolution i...

Call: OPUS 22 , Panel: NZ7

Principal investigator: dr Magdalena Olbryt

Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Oddział w Gliwicach

Inhibiting the Mitochondrial Intermembrane Space Assembly pathway as a newapproach to prevent metabolic reprogramming of...

Call: OPUS 22 , Panel: NZ5

Principal investigator: dr hab. Carlo Vascotto

Instytut Hematologii i Transfuzjologii

Development of phage-based tool with the potential to treat antibiotic-resistant gonorrhea

Call: PRELUDIUM BIS 3 , Panel: NZ6

Principal investigator: dr hab. Monika Adamczyk-Popławska

Uniwersytet Warszawski, Wydział Biologii

RE-SENSE: Dual-loaded lipid nanoparticles to overcome the resistance of non-small cell lung cancer cells to personalized...

Call: PRELUDIUM 20 , Panel: NZ7

Principal investigator: Mikołaj Czajkowski

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

In search for molecular targets to overcome doxorubicin resistance in triple-negative breast cancer with the use of inno...

Call: PRELUDIUM 20 , Panel: NZ7

Principal investigator: Anna Pogorzelska

Narodowy Instytut Leków

FGF/FGFR-signalling in mediation of resistance to therapy in triple-positive breast cancer: clinical implications of PAM...

Call: OPUS 20 , Panel: NZ4

Principal investigator: dr hab. Hanna Romańska-Knight

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Dual CBR1-AKR1C3 inhibitors as a new approach to improve effectiveness and safety of anthracycline therapy.

Call: PRELUDIUM 19 , Panel: NZ7

Principal investigator: Marek Jamrozik

Uniwersytet Jagielloński, Collegium Medicum

The significance of cancer specific PFK-II (PFKFB3 and PFKFB4) isoenzymes inhibition in overcoming resistance to BRAF in...

Call: PRELUDIUM 16 , Panel: NZ5

Principal investigator: Sonia Trojan

Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Lekarski

Role of RNA binding proteins in resistance to therapy of leukemia cells in bone marrow niche

Call: HARMONIA 10 , Panel: NZ3

Principal investigator: dr Paulina Podszywałow-Bartnicka

Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polskiej Akademii Nauk

Regulation of epithelial to mesenchymal transition and therapy resistance to antitumor therapies by MCPIP1

Call: SONATA BIS 7 , Panel: NZ5

Principal investigator: dr hab. Katarzyna Miękus

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Molecular and pharmacological approaches based on inhibition of glycolysis to overcome de novo- and antiangiogenic thera...

Call: OPUS 13 , Panel: NZ3

Principal investigator: dr hab. Beata Pająk

Wojskowy Instytut Higieny i Epidemiologii im. gen. Karola Kaczkowskiego

Protein and gene expression analysis in the course of renal cancer stem-like cells' primary resistance to sorafenib in h...

Call: PRELUDIUM 9 , Panel: NZ5

Principal investigator: Zofia Bielecka

Wojskowy Instytut Medyczny